Ignite Creation Date:
2024-05-05 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00487123
Status:
COMPLETED
Last Update Posted:
2008-06-17
First Post:
2007-06-13
Brief Title:
Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan-Hydrochlorothiazide HCTZ at 6 Months
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A Multi-Center Randomized Proof-of-Concept Parallel Control Study With Remind Cap in Patients With Essential Hypertension and Newly Treated With Valsartan-Hydrochlorothiazide HCTZ
Status:
COMPLETED
Status Verified Date:
2008-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the efficacy of the reminder device Remind Cap in improving patients compliance in the consumption of Valsartan - Hydrochlorothiazide HCTZ in the treatment of hypertension
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None